PrecisionMed Inc. Launches Amyotrophic Lateral Sclerosis (ALS) Cerebrospinal Fluid Registry
8/29/2012 10:13:08 AM
N DIEGO--(BUSINESS WIRE)--PrecisionMed Inc., the world’s leading supplier of human cerebrospinal fluid (CSF), today announced enrollment of the first donor into the PrecisionMed Amyotrophic Lateral Sclerosis (ALS) Registry. The PrecisionMed ALS Registry is a biological sample bank of DNA and longitudinal CSF, RNA, serum and plasma linked to clinical data utilizing PrecisionMed’s clinical data procurement and clinical sample management capabilities. The PrecisionMed ALS Registry is expected to be of value for the discovery and/or validation of biomarkers for neurodegenerative disease.
comments powered by